Antiphospholipid Syndrome in Systemic Autoimmune Diseases ( Volume 12 )

Publication series ：Volume 12

Author： Cervera   R.;Cervera   Ricard;Asherson   Ronald  

Publisher： Elsevier Science‎

Publication year： 2009

E-ISBN: 9780080932347

P-ISBN(Paperback): 9780444531698

P-ISBN(Hardback):  9780444531698

Subject： R392 medical immunology

Language： ENG

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Description

Antiphospholipid syndrome is an autoimmune disease that causes abnormal blood clots. It is now recognized as a major cause of common conditions, including stroke, heart attack, miscarriage, epilepsy and memory loss and as such is gaining recognition in all branches of medicine, from obstetrics to cardiology, from psychiatry to orthopedics.

This book provides an overview of our current understanding of this major disease. It includes the latest information on the new pathogenetic mechanisms involved as well as clinical manifestations in both “the thrombotic” and “non-thrombotic” manifestations of this important disease.

* Comprehensive review of this major disease
* Includes information on treatment options available

Chapter

Front cover

pp.：  1 – 4

Antiphospholipid Syndrome in Systemic Autoimmune Diseases

pp.：  4 – 5

Copyright page

pp.：  5 – 6

Dedication

pp.：  6 – 8

Preface

pp.：  8 – 10

Series Editor

pp.：  10 – 12

Volume Editor

pp.：  12 – 14

List of contributors

pp.：  14 – 18

Contents

pp.：  18 – 20

Chapter 1. History, Classification, and Subsets of the Antiphospholipid Syndrome

pp.：  20 – 32

Chapter 2. Epidemiology of the Antiphospholipid Syndrome

pp.：  32 – 54

Chapter 3. Laboratory Heterogeneity of Antiphospholipid Antibodies

pp.：  54 – 74

Chapter 4. Mechanisms of Action of Antiphospholipid Antibodies

pp.：  74 – 88

Chapter 5. Tissue Factor in Antiphospholipid Antibody-induced Pregnancy Loss: Thrombosis versus Inflammation

pp.：  88 – 100

Chapter 6. Genetic Aspects of the Antiphospholipid Syndrome: HLA Associations

pp.：  100 – 110

Chapter 7. Genetic Aspects of the Antiphospholipid Syndrome: Association with Clinical Manifestations

pp.：  110 – 124

Chapter 8. Systemic Manifestations of the Antiphospholipid Syndrome

pp.：  124 – 136

Chapter 9. Obstetric Manifestations of the Antiphospholipid Syndrome

pp.：  136 – 144

Chapter 10. Pediatric Antiphospholipid Syndrome

pp.：  144 – 158

Chapter 11. Antiphospholipid Antibodies, Infections, and Drugs

pp.：  158 – 168

Chapter 12. Antiphospholipid Syndrome Associated with Malignancies

pp.：  168 – 174

Chapter 13. Antiphospholipid Antibodies and Vasculitis

pp.：  174 – 188

Chapter 14. Antiphospholipid Antibodies and Atherosclerosis

pp.：  188 – 204

Chapter 15. Treatment of Thrombosis in the Antiphospholipid Syndrome

pp.：  204 – 212

Chapter 16. Treatment of Infertility and Early Pregnancy Loss in the Antiphospholipid Syndrome

pp.：  212 – 222

Chapter 17. Treatment of Late Pregnancy Complications in the Antiphospholipid Syndrome

pp.：  222 – 234

Chapter 18. Difficult Clinical Situations in the Antiphospholipid Syndrome

pp.：  234 – 254

Chapter 19. Future of the Antiphospholipid Syndrome

pp.：  254 – 262

Index

pp.：  262 – 273

The users who browse this book also browse